Loneliness, stress, and social isolation as a result of COVID-19 exacerbated and intensified visual hallucinations in blind people with Charles Bonnet Syndrome by 56%.
35% of patients who used ketamine to manage pain reported significant side effects ranging from hallucination, out-of-body experiences, visual disturbances, and urinary dysfunction. 20% of the side effects were linked directly to ketamine, and 15% associated with ketamine in combination with other drugs.
Researchers have identified functional connectivity problems in brain regions associated with visual processing and attention in Parkinson's patients who experience visual hallucinations.
Researchers have identified an early vulnerability biomarker for psychosis.
Researchers have developed a new method to induce visual hallucinations in healthy people. The study could help to develop new treatments to control hallucinations in people with Parkinson's and other disorders.
Neuroimaging study reveals what happens in the brain when people experience visual hallucinations associated with LSD use.
